• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无症状患者肝酶升高:调查与结果

Raised liver enzymes in asymptomatic patients: investigation and outcome.

作者信息

Goddard C J, Warnes T W

机构信息

Liver Unit, Manchester Royal Infirmary, UK.

出版信息

Dig Dis. 1992;10(4):218-26. doi: 10.1159/000171360.

DOI:10.1159/000171360
PMID:1521349
Abstract

Asymptomatic patients with raised liver enzymes are frequently encountered in clinical practice. The commonest lesion in such patients appears to be fatty liver, which may be found in those only modestly overweight. Proven treatments other than abstention from alcohol and weight loss are available for approximately 20% of asymptomatic people with abnormal liver enzymes. However, if experimental therapies are taken into account this would rise to over 50%, making an early accurate diagnosis important. Most conditions can be diagnosed non-invasively, especially in those people with markedly abnormal transaminases. The recent introduction of new non-invasive tests decreases the need for liver biopsy for diagnostic purposes, however liver biopsy retains an important role in establishing patient prognosis and response to treatment.

摘要

临床上经常会遇到肝功能酶升高但无症状的患者。这类患者最常见的病变似乎是脂肪肝,在体重仅略有超重的人群中也可能出现。除了戒酒和减肥外,约20%无症状肝功能酶异常的患者有已证实有效的治疗方法。然而,如果将实验性疗法考虑在内,这一比例将升至50%以上,因此早期准确诊断很重要。大多数情况可以通过非侵入性方法诊断,尤其是转氨酶明显异常的患者。最近新的非侵入性检测方法的引入减少了诊断性肝活检的需求,然而肝活检在确定患者预后和对治疗的反应方面仍起着重要作用。

相似文献

1
Raised liver enzymes in asymptomatic patients: investigation and outcome.无症状患者肝酶升高:调查与结果
Dig Dis. 1992;10(4):218-26. doi: 10.1159/000171360.
2
[Determination of serum procollagen-III peptide in chronic liver diseases. Clinical usefulness].[慢性肝病中血清Ⅲ型前胶原肽的测定。临床应用价值]
Minerva Med. 1992 Nov;83(11):715-20.
3
[The patient with slightly increased liver function tests].[肝功能检查结果略有升高的患者]
Praxis (Bern 1994). 2005 Feb 2;94(5):139-43. doi: 10.1024/0369-8394.94.5.139.
4
[Differential diagnosis of elevated transaminases].[转氨酶升高的鉴别诊断]
Arch Pediatr. 2001 May;8(5):535-8. doi: 10.1016/s0929-693x(00)00263-3.
5
[Diagnostic evaluation of percutaneous blind liver biopsy].经皮盲目肝脏活检的诊断评估
Lijec Vjesn. 1974 Dec;96(12):766-72.
6
Abnormal liver tests as an initial presentation of celiac disease.异常肝功能检查作为乳糜泻的首发表现
Dig Dis Sci. 2007 Nov;52(11):3016-8. doi: 10.1007/s10620-006-9149-6. Epub 2007 May 26.
7
Liver guide for monitoring of chronic hepatitis C.慢性丙型肝炎监测肝脏指南。
Proc AMIA Symp. 2000:340-3.
8
Patients with persistent elevation of aminotransferases: investigation with ultrasonography, radionuclide imaging and liver biopsy.转氨酶持续升高的患者:采用超声检查、放射性核素成像及肝活检进行检查。
J Intern Med. 1993 Jan;233(1):7-12. doi: 10.1111/j.1365-2796.1993.tb00640.x.
9
[The procollagen-III peptide in the clinical surveillance of alcoholic hepatopathy and other chronic hepatopathies].[前胶原III肽在酒精性肝病及其他慢性肝病临床监测中的应用]
Recenti Prog Med. 1994 Sep;85(9):425-8.
10
[Serum aminoterminal procollagen type-III peptide in the diagnosis of chronic hepatopathies].
Med Clin (Barc). 1992 May 30;99(1):1-5.

引用本文的文献

1
Anti-, Antioxidant Activities, and Oral Acute Toxicity of Organics Extracts from the Root Bark of Guill. and Perr.Guill. 和 Perr. 根皮有机提取物的抗氧化活性及经口急性毒性
J Trop Med. 2024 Sep 6;2024:1330063. doi: 10.1155/2024/1330063. eCollection 2024.
2
Extract: Phytochemical Characterization and Acute and Repeated Dose 28-Day Oral Toxicity Studies in Mice.提取:植物化学成分表征及急性和重复 28 天经口毒性研究在小鼠中。
Biomed Res Int. 2020 Sep 26;2020:1976298. doi: 10.1155/2020/1976298. eCollection 2020.
3
Racial disparities in the proportion of current, unresolved hepatitis C virus infections in the United States, 2003-2010.
2003-2010 年美国目前未解决的丙型肝炎病毒感染比例中的种族差异。
Dig Dis Sci. 2014 Aug;59(8):1950-7. doi: 10.1007/s10620-014-3059-9. Epub 2014 Feb 27.